164 related articles for article (PubMed ID: 28992060)
21. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Lee GH; Cheon J; Kim D; Jun HS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
[TBL] [Abstract][Full Text] [Related]
22. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
24. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
27. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
28. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
29. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
30. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
31. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
32. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
34. PP2 Ameliorates Renal Fibrosis by Regulating the NF-
Wei J; Deng X; Li Y; Li R; Yang Z; Li X; Song S; Shi Y; Duan H; Wu H
Oxid Med Cell Longev; 2021; 2021():7394344. PubMed ID: 34580604
[TBL] [Abstract][Full Text] [Related]
35. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
Zhang X; Guan T; Yang B; Gu HF; Chi Z
Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
[TBL] [Abstract][Full Text] [Related]
36. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
37. Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
Guo Y; Ran Z; Zhang Y; Song Z; Wang L; Yao L; Zhang M; Xin J; Mao X
Biomed Pharmacother; 2020 Nov; 131():110684. PubMed ID: 33152903
[TBL] [Abstract][Full Text] [Related]
38. The role of hypoxia and Morg1 in renal injury.
Loeffler I; Wolf G
Eur J Clin Invest; 2015 Mar; 45(3):294-302. PubMed ID: 25615026
[TBL] [Abstract][Full Text] [Related]
39. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model.
Yu J; Dong R; Da J; Li J; Yu F; Zha Y
Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283
[TBL] [Abstract][Full Text] [Related]
40. Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
Zhang J; Cao P; Gui J; Wang X; Han J; Wang Y; Wang G
Life Sci; 2019 Apr; 223():194-201. PubMed ID: 30898648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
